Atherosclerosis Cardiovascular DiseaseIRE-HTNCT07665034
Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
A study testing Squatting Exercise and Stretching (Yoga) Exercise in people with Atherosclerosis Cardiovascular Disease, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Background: Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Atherosclerosis Cardiovascular Disease
- What is being tested?
- Squatting Exercise and Stretching (Yoga) Exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteHong Kong
- Study dates
- 16 Apr 2025to 30 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- asymptomatic clinically stable adults
- aged >18 years
- Both genders
- Suboptimal BP (on stable medication) with SBP 135-160mmHG on ambulatory BP monitoring (AMBP)
- Agreeable to no drug changes in coming 1 year 24 weeks
- Agreeable to provide informed written consent form
- Agreeable to have AMBP and ultrasonic (FMD \& IMT) scan third (baseline, 24 weeks and preferably 1 year)
Who cannot join
- relative contraindications to AMBP (e.g. atrial fibrillation)
- severe osteoarthritis of knee
- known secondary HT
- pregnancy/breastfeeding
- active malignancy
- Serious coronary profiles, (unstable angina), renal or hepatic derangement
- Need to change medications for control BP at 24 weeks ( SBP>160 mmHg)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
The Chinese University of Hong Kong, Department of Medicine & Therapeutics
Shatin
Kam Sang Woo, MBBS, MD, FACC, +852 26474966, kamsangwoo@cuhk.edu.hk
Daphne Chu, daphne.chu@cuhk.edu.hk
About this study
Official title: The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension: A Substudy of Randomized Controlled Trial
Background:
Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contraction with minimal change in muscle length and joint angle. Most randomized trials of IRE are short duration and their long-term effects on BP and atherosclerotic complications, particularly in the Chinese, remain unknown.
Read more
Study objectives:
(i) To evaluate the impact of IRE on atherogenesis surrogates (brachial flow-mediated dilation, FMD and carotid intima-media thickness IMT).
(ii) To evaluate the impact of IRE on mechanisms of atherogenesis improvement, inflammatory parameters, arterial wall stiffness and biochemical profiles.
Setting:
Randomized samples of 200 HT patients, aged >18years with systolic BP 135-160mHg while on no or stable anti-HT medications.
Design: Randomized controlled IRE trial - stratified randomization with randomization block size of 4.
- 100 patients for wall squat exercise of 14 mins each session (2 mins IRE x 4 sets, 2 mins rest in between), 3 sessions per week, for 1 year, plus advice on healthy diet and lifestyle.
- 100 control patients (usual care) with advice on diet and healthy lifestyles and simple stretching exercise programme for 1 year.
Main outcome measures:
- Brachial FMD and carotid IMT at baseline, 24 weeks and 1 year. (primary outcome)
- Carotid-femoral pulse wave velocity (cf-PWV) at baseline and 24 weeks. (secondary outcome)
- Important atherosclerosis risk factor parameters at baseline, 24 weeks and 1 year - including fasting serum glucose, lipid profiles, HgbA1-C, creatinine, hs-CRP, CBP, fibrinogen, and interleukin 6 (IL-6). (secondary outcome)
- Safety profiles (if any) including CVS event and hospitalization at 1 year.
Expected results:
A group absolute difference in FMD of 1%, and in carotid IMT of 0.06mm between IRE intervention and control groups.
Implications: IRE as suggested will be beneficial to management of HT for atherosclerosis preventions.
Read the detailed description
- Introduction Hypertension (HT) is the most common condition worldwide predisposing to atherosclerotic diseases (stroke, heart attack and peripheral vascular disease), apart from other traditional risk factors [1-3]. However, most HT patients have suboptimal BP control despite anti-HT medications [4]. On this issue, aerobic and dynamic exercise are effective in BP-reduction, but HT-patients often have poor compliance with exercise, mainly because of requirement of additional time, skill training, venue and equipments [5-6]. Isometric resistance exercised (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contractions with minimal change in muscle length and joint angle. However, most randomized trials of IRE have short duration and their long-term effect on BP-reduction, mechanisms and atherosclerosis complications, particularly in the Chinese, remain unknown [7-11]. Much advance in noninvasive vessel-imaging has been witnessed in past few decades. Brachial flow-mediated dilation (FMD) and carotid intima-media thickness (IMT), have been advocated as surrogate markers for the documentation of early atherosclerosis and evaluation of preventive measures (12-20). Both brachial FMD and carotid IMT can now be measured accurately with high reproducibility, and have been related to cardiovascular outcomes. In clinical context, a 0.1mm increase in carotid IMT has been associated with 41% increase in stroke and 43% increase in acute myocardial infarction over a follow-up period of 2-7 years. [17] An 8% difference in carotid IMT was approximately similar to the kind of difference seen between diabetes and non-diabetes Chinese adults [21).
- Aims and Hypotheses to be Tested Systemic hypertension has been proven accelerating atherosclerotic process. To further test this initial hypothesis, this interventional substudy aims: (i) To evaluate the impact of IRE on atherosclerotic surrogates (brachial FMD and carotid IMT). (ii) To evaluate the impact of IRE on mechanisms of BP and atherogenesis reductions, including endothelial function FMD, carotid IMT and arterial wall stiffness (cfPWV), and inflammatory parameters.
- Plan of Investigation The brachial FMD and carotid IMT before and after IRE intervention will be compared between the wall-squat and control intervention groups.
3.1 The impact of Isometric resistance exercise (IRE) Intervention on brachial FMD and carotid IMT.
Subjects:
200 HT adults, aged >18 years with SBP 135-160mmHg on AMBP will be recruited. Those with incapacitating osteoarthritis of knee and secondary HT will be excluded.
3.2 Methods: These HT participants will be randomized to practise IRE (100 adults) 14 mins per session, (2 mins IRE x 4sets, 2 mins rest in between), 3 sessions per week, or usual standard care \& stretching (yoga) exercise (100 adults).
Week-0 ~ Health Examination, Randomization (IRE vs Yoga), Vascular Study (FMD \& IMT), Blood Test, and Arterial wall stiffness (cfPWV)
Week-13 ~ Compliance (adhenence) checking
Week-24 ~ Health Examination, vascular study (FMD \& IMT), blood tests, and arterial wall stiffness (cfPWV)
One Year ~ Compliance (adherence) checking, vascular study (FMD \& IMT), vessel wall stiffness, and blood Tests
- Collection of health data:
- Questionnaire - All adult subjects will be interviewed and required to complete a detailed questionnaire regarding their individual and family history of cardiovascular diseases, hypertension, diabetes and current use of medications. Information on socio-economic status, tobacco use and lifestyle will be collected.
- Health examination - Each participant will receive a health examination and their weight and height, blood pressures, body mass index (BMI) and wait-hip circumference ratio (WHR) will be measured (light clothing and no shoes).
- Blood tests: 10ml of fasting blood will be taken for WBC platelet, fasting glucose, HgbA1C, low density lipoprotein cholesterol, hsC-reactive protein, fibrinogen and IL-6.
- Vascular Studies:
Endothelial function, flow-mediated dilation (FMD) of the brachial artery and carotid IMT will be studied by using high resolution ultrasound.
(i) Endothelial function, (brachial flow-mediated dilation, FMD) will be studied by using high resolution ultrasound, as described previously. [12,22-24] In brief, the diameter of the brachial artery will be measured on B-mode ultrasound images, using a linear array transducer (HF L38) with a median frequency of 13-6MHz and a standard Sonosite (MicroMaxx) system. Forearm tourniquet cuff placement will be applied to induce reactive hyperemia on deflation. Scans of brachial artery 10cm proximal to elbow will be acquired at rest, during reactive hyperemia (to induce flow-mediated endothelium-dependent dilation, FMD). FMD will be expressed as % of dilation from baseline vessel diameter normalized with vessel strain. Hyperemia is calculated as the % increase in blood flow after cuff deflation compared with baseline.
(ii) Carotid intima-media thickness (CIMT) measurement - B-mode ultrasound examinations will be performed using a 10-5 probe, with a 7.5 MHz scanning frequency linear array transducer. All carotid scans will be performed by a single operator after a predetermined, standardized scanning protocol for the right and left carotid arteries as described by Salonen and Salonen [16] and Touboul et al [19], using images of the far wall of the distal 10 mm of the common carotid arteries. All scans will be recorded on super-VHS videotape for subsequent off-line analysis for intima-media thickness (IMT), using a verified automatic edge-detecting and measurement software package as described previously. [19-24] The intra-observer variability of mean IMT is 0.003 to 0.011mm (CV 0.998%).
3.3 Outcomes
3.3.1 Primary outcomes: Vascular Parameters: Brachial FMD (%) and Carotid IMT (mm) at baseline, 24 weeks and 1 year.
3.3.2 Secondary outcomes: (i) Carotid femoral pulse wave velocity, cfPWV (mm/sec) at baseline and 24 weeks.
(ii) Other important traditional atherosclerosis risk factors: BMI (weight kg/ height m^2), glucose (mmol/l), lipid profiles (mmol/l), HgbA1-C (%), creatinine (umol/L), haemoglobin (g/dl), hsCRP (mg/l), Fibrinogen (mg/dl) and IL-6 (pg/ml) at baseline, 24 weeks and 1 year.
3.3.3 Safety profiles (if any) including CVS event and hospitalization at 1 year,
- Compliance with Declaration of Helsinki. The design, methodology and conduction of project are in compliance with Declaration of Helsinki.
- Data processing and analysis: (5.1) Power Calculation: The Proc Power in the STS 9.2 statistical packages (SAS Institute Inc. Cary. NC, US) was used to calculate the sample size for FMD and carotid IMT. Data from our previous studies on Chinese adults in Hong Kong reported FMD was in 6-8% +/- 1.3%, and carotid IMT was 0.55-0.68mm +/- 0.1mm. On the assumption of post IRE brachial FMD will improve to 6.7-8.7 +/- 1.4%, and carotid IMT will reduce to 0.51-0.61mm +/- 0.11mm, recruitment of 200 Chinese adults (100 in each group) will be adequately powered (85%) to detect a group difference in brachial FMD of 1.2% and in carotid IMT of 0.06mm (12%), at 1 year between the two treatment groups. (5.2). Data Analysis: Statistical Analysis System SPSS version 28 (SAS Institute Inc., Cary, NC, US) will be used for all statistical analyses. Descriptive methods will be used to describe characteristics of cardiovascular risks. The primary endpoints are AMBP, brachial FMD and carotid IMT; serological inflammatory biomarkers (Neutrophil/ monocyte ratio and Platelet), hsCRP, fibrinogen and IL-6 are secondary endpoints. Students' T-tests will be used to detect the group differences in brachial FMD and carotid IMT. Multivariable linear and logistic regressions will be used to calculate the risk magnitude by IRE vs usual care and stretching exercise interventions, and to control potential confounders such as traditional cardiovascular risk factors.
- Conditions
- Atherosclerosis Cardiovascular Disease
- Being tested
- Squatting Exercise, Stretching (Yoga) Exercise
- Keywords
- Isometric Resistance Exercise, Essential Hypertension, Atherosclerosis, Brachial FMD, Carotid IMT, Atherosclerosis Prevention
- Medical subject headings
- Essential Hypertension, Atherosclerosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Squatting ExerciseOther
14 minutes per session (2 mins x 4 sets, 2 mins rest in between, 3 session per week)
Stretching (Yoga) ExerciseOther
2 mins x 4 sets, 2 mins rest in between, 3 sessions per week
| Study group | Role | What they receive |
|---|---|---|
| Anti HT + Isometric Resistance Squatting Exercise (100 Adults) | Active comparator | A more linear thigh-leg squatting angle is allowed in initial 2 weeks, but aiming at 90 degree thigh-leg angle after 4 weeks. Receives: Other: Squatting Exercise |
| Anti HT + Stretching Exercise (100 Adults) | Active comparator | A liberal leg stretching excerise will be practised Receives: Other: Stretching (Yoga) Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Changes in Brachial FMD (%)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Changes in Carotid IMT (mm)
Measured: Baseline, 24 weeks and 1 year
Secondary outcomes (10)
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Changes in Carotid femoral pulse wave velocity, cfPWV (mm/sec)
Measured: Baseline and 24 weeks
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Other important traditional atherosclerosis risk factors:
Changes in BMI (weight kg/ height m^2)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Changes in Fasting Glucose (mmol/l)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Changes in Fasting Lipid profiles (mmol/l)
- Changes in high density lipoprotein cholesterol (HDL-C) (mmol/l)
- Changes in low density lipoprotein cholesterol (LDL-C) (mmol/l)
- Changes in Triglyceride (TG) (mmol/l)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
HgbA1-C (%)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Creatinine (umol/L)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Haemoglobin (g/dl)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
hsCRP (mg/l)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Fibrinogen (mg/dl)
Measured: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
IL-6 (pg/ml)
Measured: Baseline, 24 weeks and 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jun 2026
- Study start16 Apr 2025
- Primary completion30 Jul 2027 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (23)Papers the sponsor has linked to this study.
- Other trials for Atherosclerosis Cardiovascular DiseaseStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kam Sang WOO, Chinese University of Hong Kong
- Investigators
- Kam Sang Woo, Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07665034
- Sponsor's protocol ID
- 2022-618-T
- Acronym
- IRE-HT
- Status last verified
- Jun 2026
- First submitted
- 17 Sep 2025
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: There is a plan to make IPD and related data dictionaries available. All IPD that underline results in a publication.
Publications
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043.
PubMed 28097354Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.
PubMed 24002282Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78. doi: 10.1161/CIR.0b013e3181dbece1. Epub 2010 May 10.
PubMed 20458016Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3.
PubMed 36056737Moncion K, Biasin L, Jagroop D, Bayley M, Danells C, Mansfield A, Salbach NM, Inness E, Tang A. Barriers and Facilitators to Aerobic Exercise Implementation in Stroke Rehabilitation: A Scoping Review. J Neurol Phys Ther. 2020 Jul;44(3):179-187. doi: 10.1097/NPT.0000000000000318.
PubMed 32516297Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002 Apr 2;136(7):493-503. doi: 10.7326/0003-4819-136-7-200204020-00006.
PubMed 11926784Smart NA, Gow J, Bleile B, Van der Touw T, Pearson MJ. An evidence-based analysis of managing hypertension with isometric resistance exercise-are the guidelines current? Hypertens Res. 2020 Apr;43(4):249-254. doi: 10.1038/s41440-019-0360-1. Epub 2019 Nov 22.
PubMed 31758166Hansford HJ, Parmenter BJ, McLeod KA, Wewege MA, Smart NA, Schutte AE, Jones MD. The effectiveness and safety of isometric resistance training for adults with high blood pressure: a systematic review and meta-analysis. Hypertens Res. 2021 Nov;44(11):1373-1384. doi: 10.1038/s41440-021-00720-3. Epub 2021 Aug 12.
PubMed 34385688Loaiza-Betancur AF, Chulvi-Medrano I. Is Low-Intensity Isometric Handgrip Exercise an Efficient Alternative in Lifestyle Blood Pressure Management? A Systematic Review. Sports Health. 2020 Sep/Oct;12(5):470-477. doi: 10.1177/1941738120943882. Epub 2020 Aug 10.
PubMed 32776866Smart NA, Way D, Carlson D, Millar P, McGowan C, Swaine I, Baross A, Howden R, Ritti-Dias R, Wiles J, Cornelissen V, Gordon B, Taylor R, Bleile B. Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis. J Hypertens. 2019 Oct;37(10):1927-1938. doi: 10.1097/HJH.0000000000002105.
PubMed 30889048Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7;340(8828):1111-5. doi: 10.1016/0140-6736(92)93147-f.
PubMed 1359209Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000 Jul 15;86(2):207-10. doi: 10.1016/s0002-9149(00)00857-2. No abstract available.
PubMed 10913483Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie MA, Morgan TM, Espeland MA. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 2001 Oct;8(5):319-28. doi: 10.1177/174182670100800512.
PubMed 11702039Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003 May 21;41(10):1769-75. doi: 10.1016/s0735-1097(03)00333-4.
PubMed 12767663Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1245-9. doi: 10.1161/01.atv.11.5.1245.
PubMed 1911709
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension: A Substudy of Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07665034
- Acronym / sponsor ID
- IRE-HT / 2022-618-T
- Conditions
- Atherosclerosis Cardiovascular Disease
- Keywords
- Isometric Resistance Exercise, Essential Hypertension, Atherosclerosis, Brachial FMD, Carotid IMT, Atherosclerosis Prevention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 16 Apr 2025 (actual)
- Primary completion
- 30 Jul 2027 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 24 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contraction with minimal change in muscle length and joint angle. Most randomized trials of IRE are short duration and their long-term effects on BP and atherosclerotic complications, particularly in the Chinese, remain unknown.
Study objectives:
(i) To evaluate the impact of IRE on atherogenesis surrogates (brachial flow-mediated dilation, FMD and carotid intima-media thickness IMT).
(ii) To evaluate the impact of IRE on mechanisms of atherogenesis improvement, inflammatory parameters, arterial wall stiffness and biochemical profiles.
Setting:
Randomized samples of 200 HT patients, aged >18years with systolic BP 135-160mHg while on no or stable anti-HT medications.
Design: Randomized controlled IRE trial - stratified randomization with randomization block size of 4.
- 100 patients for wall squat exercise of 14 mins each session (2 mins IRE x 4 sets, 2 mins rest in between), 3 sessions per week, for 1 year, plus advice on healthy diet and lifestyle.
- 100 control patients (usual care) with advice on diet and healthy lifestyles and simple stretching exercise programme for 1 year.
Main outcome measures:
- Brachial FMD and carotid IMT at baseline, 24 weeks and 1 year. (primary outcome)
- Carotid-femoral pulse wave velocity (cf-PWV) at baseline and 24 weeks. (secondary outcome)
- Important atherosclerosis risk factor parameters at baseline, 24 weeks and 1 year - including fasting serum glucose, lipid profiles, HgbA1-C, creatinine, hs-CRP, CBP, fibrinogen, and interleukin 6 (IL-6). (secondary outcome)
- Safety profiles (if any) including CVS event and hospitalization at 1 year.
Expected results:
A group absolute difference in FMD of 1%, and in carotid IMT of 0.06mm between IRE intervention and control groups.
Implications: IRE as suggested will be beneficial to management of HT for atherosclerosis preventions.
Detailed description
- Introduction Hypertension (HT) is the most common condition worldwide predisposing to atherosclerotic diseases (stroke, heart attack and peripheral vascular disease), apart from other traditional risk factors [1-3]. However, most HT patients have suboptimal BP control despite anti-HT medications [4]. On this issue, aerobic and dynamic exercise are effective in BP-reduction, but HT-patients often have poor compliance with exercise, mainly because of requirement of additional time, skill training, venue and equipments [5-6]. Isometric resistance exercised (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contractions with minimal change in muscle length and joint angle. However, most randomized trials of IRE have short duration and their long-term effect on BP-reduction, mechanisms and atherosclerosis complications, particularly in the Chinese, remain unknown [7-11]. Much advance in noninvasive vessel-imaging has been witnessed in past few decades. Brachial flow-mediated dilation (FMD) and carotid intima-media thickness (IMT), have been advocated as surrogate markers for the documentation of early atherosclerosis and evaluation of preventive measures (12-20). Both brachial FMD and carotid IMT can now be measured accurately with high reproducibility, and have been related to cardiovascular outcomes. In clinical context, a 0.1mm increase in carotid IMT has been associated with 41% increase in stroke and 43% increase in acute myocardial infarction over a follow-up period of 2-7 years. [17] An 8% difference in carotid IMT was approximately similar to the kind of difference seen between diabetes and non-diabetes Chinese adults [21).
- Aims and Hypotheses to be Tested Systemic hypertension has been proven accelerating atherosclerotic process. To further test this initial hypothesis, this interventional substudy aims: (i) To evaluate the impact of IRE on atherosclerotic surrogates (brachial FMD and carotid IMT). (ii) To evaluate the impact of IRE on mechanisms of BP and atherogenesis reductions, including endothelial function FMD, carotid IMT and arterial wall stiffness (cfPWV), and inflammatory parameters.
- Plan of Investigation The brachial FMD and carotid IMT before and after IRE intervention will be compared between the wall-squat and control intervention groups.
3.1 The impact of Isometric resistance exercise (IRE) Intervention on brachial FMD and carotid IMT.
Subjects:
200 HT adults, aged >18 years with SBP 135-160mmHg on AMBP will be recruited. Those with incapacitating osteoarthritis of knee and secondary HT will be excluded.
3.2 Methods: These HT participants will be randomized to practise IRE (100 adults) 14 mins per session, (2 mins IRE x 4sets, 2 mins rest in between), 3 sessions per week, or usual standard care \& stretching (yoga) exercise (100 adults).
Week-0 ~ Health Examination, Randomization (IRE vs Yoga), Vascular Study (FMD \& IMT), Blood Test, and Arterial wall stiffness (cfPWV)
Week-13 ~ Compliance (adhenence) checking
Week-24 ~ Health Examination, vascular study (FMD \& IMT), blood tests, and arterial wall stiffness (cfPWV)
One Year ~ Compliance (adherence) checking, vascular study (FMD \& IMT), vessel wall stiffness, and blood Tests
- Collection of health data:
- Questionnaire - All adult subjects will be interviewed and required to complete a detailed questionnaire regarding their individual and family history of cardiovascular diseases, hypertension, diabetes and current use of medications. Information on socio-economic status, tobacco use and lifestyle will be collected.
- Health examination - Each participant will receive a health examination and their weight and height, blood pressures, body mass index (BMI) and wait-hip circumference ratio (WHR) will be measured (light clothing and no shoes).
- Blood tests: 10ml of fasting blood will be taken for WBC platelet, fasting glucose, HgbA1C, low density lipoprotein cholesterol, hsC-reactive protein, fibrinogen and IL-6.
- Vascular Studies:
Endothelial function, flow-mediated dilation (FMD) of the brachial artery and carotid IMT will be studied by using high resolution ultrasound.
(i) Endothelial function, (brachial flow-mediated dilation, FMD) will be studied by using high resolution ultrasound, as described previously. [12,22-24] In brief, the diameter of the brachial artery will be measured on B-mode ultrasound images, using a linear array transducer (HF L38) with a median frequency of 13-6MHz and a standard Sonosite (MicroMaxx) system. Forearm tourniquet cuff placement will be applied to induce reactive hyperemia on deflation. Scans of brachial artery 10cm proximal to elbow will be acquired at rest, during reactive hyperemia (to induce flow-mediated endothelium-dependent dilation, FMD). FMD will be expressed as % of dilation from baseline vessel diameter normalized with vessel strain. Hyperemia is calculated as the % increase in blood flow after cuff deflation compared with baseline.
(ii) Carotid intima-media thickness (CIMT) measurement - B-mode ultrasound examinations will be performed using a 10-5 probe, with a 7.5 MHz scanning frequency linear array transducer. All carotid scans will be performed by a single operator after a predetermined, standardized scanning protocol for the right and left carotid arteries as described by Salonen and Salonen [16] and Touboul et al [19], using images of the far wall of the distal 10 mm of the common carotid arteries. All scans will be recorded on super-VHS videotape for subsequent off-line analysis for intima-media thickness (IMT), using a verified automatic edge-detecting and measurement software package as described previously. [19-24] The intra-observer variability of mean IMT is 0.003 to 0.011mm (CV 0.998%).
3.3 Outcomes
3.3.1 Primary outcomes: Vascular Parameters: Brachial FMD (%) and Carotid IMT (mm) at baseline, 24 weeks and 1 year.
3.3.2 Secondary outcomes: (i) Carotid femoral pulse wave velocity, cfPWV (mm/sec) at baseline and 24 weeks.
(ii) Other important traditional atherosclerosis risk factors: BMI (weight kg/ height m^2), glucose (mmol/l), lipid profiles (mmol/l), HgbA1-C (%), creatinine (umol/L), haemoglobin (g/dl), hsCRP (mg/l), Fibrinogen (mg/dl) and IL-6 (pg/ml) at baseline, 24 weeks and 1 year.
3.3.3 Safety profiles (if any) including CVS event and hospitalization at 1 year,
- Compliance with Declaration of Helsinki. The design, methodology and conduction of project are in compliance with Declaration of Helsinki.
- Data processing and analysis: (5.1) Power Calculation: The Proc Power in the STS 9.2 statistical packages (SAS Institute Inc. Cary. NC, US) was used to calculate the sample size for FMD and carotid IMT. Data from our previous studies on Chinese adults in Hong Kong reported FMD was in 6-8% +/- 1.3%, and carotid IMT was 0.55-0.68mm +/- 0.1mm. On the assumption of post IRE brachial FMD will improve to 6.7-8.7 +/- 1.4%, and carotid IMT will reduce to 0.51-0.61mm +/- 0.11mm, recruitment of 200 Chinese adults (100 in each group) will be adequately powered (85%) to detect a group difference in brachial FMD of 1.2% and in carotid IMT of 0.06mm (12%), at 1 year between the two treatment groups. (5.2). Data Analysis: Statistical Analysis System SPSS version 28 (SAS Institute Inc., Cary, NC, US) will be used for all statistical analyses. Descriptive methods will be used to describe characteristics of cardiovascular risks. The primary endpoints are AMBP, brachial FMD and carotid IMT; serological inflammatory biomarkers (Neutrophil/ monocyte ratio and Platelet), hsCRP, fibrinogen and IL-6 are secondary endpoints. Students' T-tests will be used to detect the group differences in brachial FMD and carotid IMT. Multivariable linear and logistic regressions will be used to calculate the risk magnitude by IRE vs usual care and stretching exercise interventions, and to control potential confounders such as traditional cardiovascular risk factors.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Anti HT + Isometric Resistance Squatting Exercise (100 Adults) | Active comparator | Other: Squatting ExerciseA more linear thigh-leg squatting angle is allowed in initial 2 weeks, but aiming at 90 degree thigh-leg angle after 4 weeks. |
| Anti HT + Stretching Exercise (100 Adults) | Active comparator | Other: Stretching (Yoga) ExerciseA liberal leg stretching excerise will be practised |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- asymptomatic clinically stable adults
- aged >18 years
- Both genders
- Suboptimal BP (on stable medication) with SBP 135-160mmHG on ambulatory BP monitoring (AMBP)
- Agreeable to no drug changes in coming 1 year 24 weeks
Key exclusion criteria (7 listed)
- relative contraindications to AMBP (e.g. atrial fibrillation)
- severe osteoarthritis of knee
- known secondary HT
- pregnancy/breastfeeding
- active malignancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Squatting Exercise14 minutes per session (2 mins x 4 sets, 2 mins rest in between, 3 session per week) | Other | Anti HT + Isometric Resistance Squatting Exercise (100 Adults) |
| Stretching (Yoga) Exercise2 mins x 4 sets, 2 mins rest in between, 3 sessions per week | Other | Anti HT + Stretching Exercise (100 Adults) |
Primary outcome
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
Changes in Brachial FMD (%)
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
Changes in Carotid IMT (mm)
10 secondary outcomes
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline and 24 weeks
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Time frame: Baseline, 24 weeks and 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2026.
- Background: PubMed 28097354Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043.
- Background: PubMed 24002282Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.
- Background: PubMed 20458016Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78. doi: 10.1161/CIR.0b013e3181dbece1. Epub 2010 May 10.
- Background: PubMed 36056737Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3.
- Background: PubMed 32516297Moncion K, Biasin L, Jagroop D, Bayley M, Danells C, Mansfield A, Salbach NM, Inness E, Tang A. Barriers and Facilitators to Aerobic Exercise Implementation in Stroke Rehabilitation: A Scoping Review. J Neurol Phys Ther. 2020 Jul;44(3):179-187. doi: 10.1097/NPT.0000000000000318.
- Background: PubMed 11926784Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002 Apr 2;136(7):493-503. doi: 10.7326/0003-4819-136-7-200204020-00006.
- Background: PubMed 31758166Smart NA, Gow J, Bleile B, Van der Touw T, Pearson MJ. An evidence-based analysis of managing hypertension with isometric resistance exercise-are the guidelines current? Hypertens Res. 2020 Apr;43(4):249-254. doi: 10.1038/s41440-019-0360-1. Epub 2019 Nov 22.
- Background: PubMed 34385688Hansford HJ, Parmenter BJ, McLeod KA, Wewege MA, Smart NA, Schutte AE, Jones MD. The effectiveness and safety of isometric resistance training for adults with high blood pressure: a systematic review and meta-analysis. Hypertens Res. 2021 Nov;44(11):1373-1384. doi: 10.1038/s41440-021-00720-3. Epub 2021 Aug 12.
- Background: PubMed 32776866Loaiza-Betancur AF, Chulvi-Medrano I. Is Low-Intensity Isometric Handgrip Exercise an Efficient Alternative in Lifestyle Blood Pressure Management? A Systematic Review. Sports Health. 2020 Sep/Oct;12(5):470-477. doi: 10.1177/1941738120943882. Epub 2020 Aug 10.
- Background: PubMed 30889048Smart NA, Way D, Carlson D, Millar P, McGowan C, Swaine I, Baross A, Howden R, Ritti-Dias R, Wiles J, Cornelissen V, Gordon B, Taylor R, Bleile B. Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis. J Hypertens. 2019 Oct;37(10):1927-1938. doi: 10.1097/HJH.0000000000002105.
- Background: PubMed 1359209Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov 7;340(8828):1111-5. doi: 10.1016/0140-6736(92)93147-f.
- Background: PubMed 10913483Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000 Jul 15;86(2):207-10. doi: 10.1016/s0002-9149(00)00857-2. No abstract available.
- Individual participant dataSharing planned: Yes. There is a plan to make IPD and related data dictionaries available. All IPD that underline results in a publication.
Related trials for Atherosclerosis Cardiovascular Disease
RecruitingObservational study
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Asthma, Atherosclerosis
Not yet recruitingObservational study
Qatar Cardiometabolic Cohort
Cardiometabolic Diseases
RecruitingObservational study
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease, Obesity
RecruitingObservational study
Causes and Natural History of Dyslipidemias
Hypercholesterolemia, Atherosclerosis
Active, not recruitingPhase 4
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Coronary Artery Disease, Atherosclerosis of Coronary Artery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kam Sang Woo principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Squatting Exercise and Stretching (Yoga) Exercise in people with Atherosclerosis Cardiovascular Disease, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact KS Woo, MBBS, MD, FACC (+852 26474966, kamsangwoo@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension (time frame: Baseline, 24 weeks and 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07665034, which also lists 23 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.